Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_assertion type Assertion NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_head.
- NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_assertion description "[Classification of SM patients into indolent (SM), aggressive SM (ASM), SM associated with a clonal non-MC lineage disease (SM-AHNMD), and mast cell leukemia (MCL) subgroups is a useful first step in establishing prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_provenance.
- NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_assertion evidence source_evidence_literature NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_provenance.
- NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_assertion SIO_000772 21442641 NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_provenance.
- NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_assertion wasDerivedFrom befree-20140225 NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_provenance.
- NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_assertion wasGeneratedBy ECO_0000203 NP565605.RA5bhOFP9NNQHL_ap_oWZfK3IJvHGfFC7Q---BaU64mMo130_provenance.